Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
Rapp
Jonathan A
JA
Northwestern University, Chicago, IL 60611, USA.
Gheorghiade
Mihai
M
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D003971:Diastole / Q000187:drug effects; D004341:Drug Evaluation; D019317:Evidence-Based Medicine / Q000379:methods; D005260:Female; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists; D018377:Neurotransmitter Agents / Q000378:metabolism*; D011379:Prognosis; D013599:Systole / Q000187:drug effects; D018754:Ventricular Dysfunction / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000451:Mineralocorticoid Receptor Antagonists; D018377:Neurotransmitter Agents